After 10 Years of Clinical Trials with Liraglutide in Diabetes, What do we Know About its Effects on Clinical Cardiovascular Outcomes?

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|10|1|68-77

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.10, Iss.1, 2015-05, pp. : 68-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What do we actually know about the referral process?

By Perkins Peter  

British Journal of General Practice, Vol. 62, Iss. 595, 2012-02 ,pp. : 70-70

Royal College of General Practitioners

Access to resources Recommend Favorite

What do we know about the safety of corticosteroids in rheumatoid arthritis?

By Ethgen Olivier   de Lemos Esteves Frédéric   Bruyere Olivier   Reginster Jean-Yves  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1147-1160

Informa Healthcare

Access to resources Recommend Favorite

What Do We Know About Medication Errors in Inpatient Psychiatry?

By Grasso Benjamin C.   Rothschild Jeffrey M.   Genest Robert   Bates David W.  

Joint Commission Journal on Quality and Patient Safety, Vol. 29, Iss. 8, 2003-08 ,pp. : 391-400

Joint Commission Resources

Access to resources Recommend Favorite

What do we actually know about the referral process?

By Davies Peter   Pool Roger   Smelt Graham  

British Journal of General Practice, Vol. 61, Iss. 593, 2011-12 ,pp. : 752-753

Royal College of General Practitioners

Access to resources Recommend Favorite

Clinical appearance of neuroblastoma 10 years after screening

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 1012-1014

John Wiley & Sons Inc

Access to resources Recommend Favorite